{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:02:54Z","timestamp":1792180974342,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":1617,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1093\/bja\/aet208","type":"journal-article","created":{"date-parts":[[2013,6,23]],"date-time":"2013-06-23T19:27:51Z","timestamp":1372015671000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":278,"title":["Neuropathic pain in cancer"],"prefix":"10.1016","volume":"111","author":[{"given":"M.T.","family":"Fallon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aet208_bib1","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet208_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1","article-title":"A validation study of the WHO method for cancer pain relief","volume":"59","author":"Ventafridda","year":"1987","journal-title":"Cancer"},{"key":"10.1093\/bja\/aet208_bib3","series-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","author":"Merskey","year":"1994"},{"key":"10.1093\/bja\/aet208_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11912-996-0005-9","article-title":"Peripheral neuropathy and cancer","volume":"6","author":"Forman","year":"2004","journal-title":"Curr Oncol Rep"},{"key":"10.1093\/bja\/aet208_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib6","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.ejca.2007.07.030","article-title":"Pain in oxaliplatin-induced neuropathy'sensitisation in the peripheral and central nociceptive system","volume":"43","author":"Binder","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/bja\/aet208_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2407-5-116","article-title":"Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer","volume":"5","author":"Leonard","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1093\/bja\/aet208_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1093\/bja\/aet208_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra","year":"2012","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1093\/bja\/aet208_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00023210-200620080-00010","article-title":"Pregabalin: in the treatment of generalised anxiety disorder","volume":"20","author":"Frampton","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1093\/bja\/aet208_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/pgmj.2009.080473","article-title":"Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain","volume":"87","author":"Zakrzewska","year":"2011","journal-title":"Postgrad Med J"},{"key":"10.1093\/bja\/aet208_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1093\/bja\/aet208_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death","volume":"75","author":"Ray","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/aet208_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A systematic review of antidepressants in neuropathic pain","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00002508-200003000-00002","article-title":"Efficacy of sustained-release bupropion in neuropathic pain: an open-label study","volume":"16","author":"Semenchuk","year":"2000","journal-title":"Clin J Pain"},{"key":"10.1093\/bja\/aet208_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1093\/bja\/aet208_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00044011-200727010-00007","article-title":"Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study","volume":"27","author":"Arbaiza","year":"2007","journal-title":"Clin Drug Invest"},{"key":"10.1093\/bja\/aet208_bib21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1093\/bja\/aet208_bib22","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/bja\/aet208_bib23","first-page":"CD004847","article-title":"Opioid switching to improve pain relief and drug tolerability","volume":"3","author":"Quigley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aet208_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aet208_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","article-title":"Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study","volume":"20","author":"Mercadante","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aet208_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jpm.2011.0353","article-title":"Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care","volume":"15","author":"Salas","year":"2012","journal-title":"J Palliat Med"},{"key":"10.1093\/bja\/aet208_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1093\/bja\/aet208_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpneuro0949","article-title":"Should cannabinoids be used as analgesics for neuropathic pain?","volume":"4","author":"Rice","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1093\/bja\/aet208_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(05)70024-3","article-title":"Cannabinoids and cancer: causation, remediation, and palliation","volume":"6","author":"Hall","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1093\/bja\/aet208_bib30","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD spray and THC spray in patient with cancer-related pain","author":"Johnson","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aet208_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomised, placebo-controlled parallel study group of the efficacy, safety and tolerability of tetrahydrocannabinol: cannabinol extract and tetrahydrocannabinol extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aet208_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/ern.10.182","article-title":"Qutenza(R): a capsaicin 8% patch for the management of postherpetic neuralgia","volume":"11","author":"Wallace","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1093\/bja\/aet208_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0378-6323.58686","article-title":"Comparative study of clinical efficacy with amitriptyline, pregabalin, and amitriptyline plus pregabalin combination in postherpetic neuralgia","volume":"76","author":"Achar","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1093\/bja\/aet208_bib34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"10.1093\/bja\/aet208_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1586\/14737175.5.6.823","article-title":"Combination pharmacotherapy for neuropathic pain: current evidence and future directions","volume":"5","author":"Gilron","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"10.1093\/bja\/aet208_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00540-010-0913-6","article-title":"Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine","volume":"24","author":"Arai","year":"2010","journal-title":"J Anesth"},{"key":"10.1093\/bja\/aet208_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269216310378546","article-title":"Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review","volume":"25","author":"Bennett","year":"2011","journal-title":"Palliat Med"},{"issue":"Suppl. 2","key":"10.1093\/bja\/aet208_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.2009-S504","article-title":"Integrative and behavioral approaches to the treatment of cancer-related neuropathic pain","volume":"15","author":"Cassileth","year":"2010","journal-title":"Oncologist"},{"key":"10.1093\/bja\/aet208_bib39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.pain.2011.02.026","article-title":"Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy","volume":"152","author":"Dworkin","year":"2011","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pain.2004.10.007","article-title":"Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies","volume":"113","author":"Hansson","year":"2005","journal-title":"Pain"},{"key":"10.1093\/bja\/aet208_bib41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/annonc\/mdq031","article-title":"Management of neuropathic cancer pain","volume":"21","author":"Attal","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/bja\/aet208_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1093\/bja\/aet208_bib43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/bja\/aet208_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","article-title":"Chronic pain in the cancer survivor: a new frontier","volume":"8","author":"Burton","year":"2007","journal-title":"Pain Med"},{"issue":"Suppl.","key":"10.1093\/bja\/aet208_bib45","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/1097-0142(19841201)54:2+<2635::AID-CNCR2820541407>3.0.CO;2-P","article-title":"The impact of pain on the patient with cancer","volume":"54","author":"Cleeland","year":"1984","journal-title":"Cancer"},{"key":"10.1093\/bja\/aet208_bib46","first-page":"791","article-title":"The problem of pain in outpatients with breast cancer","volume":"22","author":"Miaskowski","year":"1995","journal-title":"Oncol Nurs Forum"},{"key":"10.1093\/bja\/aet208_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1213\/01.ANE.0000133383.17666.3A","article-title":"Persistent pain as a disease entity: implications for clinical management","volume":"99","author":"Siddall","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aet208_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/djg014","article-title":"National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15\u201317, 2002","volume":"95","author":"Patrick","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/bja\/aet208_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11764-008-0047-0","article-title":"Barriers to pain assessment and management in cancer survivorship","volume":"2","author":"Sun","year":"2008","journal-title":"J Cancer Surviv"},{"key":"10.1093\/bja\/aet208_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archoto.2011.234","article-title":"Long-term health-related quality of life in survivors of head and neck cancer","volume":"138","author":"Funk","year":"2012","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1093\/bja\/aet208_bib51","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/cncr.10414","article-title":"Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control","volume":"94","author":"Anderson","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/bja\/aet208_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00003246-200102000-00010","article-title":"Self-reported symptom experience of critically ill cancer patients receiving intensive care","volume":"29","author":"Nelson","year":"2001","journal-title":"Critical Care Med"},{"key":"10.1093\/bja\/aet208_bib53","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/cncr.25761","article-title":"Cancer-related chronic pain: examining quality of life in diverse cancer survivors","volume":"117","author":"Green","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/bja\/aet208_bib54","unstructured":"M Fallon, C Loprinzi, Presentation at Multinational Association of Supportive Care in Cancer (MASCC) June 2013 (in press)."},{"key":"10.1093\/bja\/aet208_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Lavoie Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1093\/bja\/aet208_bib56","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.1997.15.8.2974","article-title":"Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients","volume":"15","author":"Ellison","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217329732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217329732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/111\/1\/105\/955569\/aet208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:41:13Z","timestamp":1757788873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217329732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0007091217329732"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aet208","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathic pain in cancer","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aet208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}